Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University of Innsbruck, Innsbruck, Austria.
Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
Cancer Med. 2018 Mar;7(3):635-645. doi: 10.1002/cam4.1338. Epub 2018 Feb 13.
To develop and pretest an European Organization for the Research and Treatment of Cancer Sexual Health Questionnaire (EORTC SHQ-22) for the assessment of physical, psychological, and social aspects of sexual health (SH) in male and female cancer patients and survivors. Questionnaire construction started with creating a list of relevant SH issues based on a comprehensive literature review. Issues were subsequently evaluated for relevance and prioritization by 78 healthcare professionals (HCP) and 107 patients from 12 countries during in-depth interviews (phase 1). Extracted issues were operationalized into items (phase 2). Phase 3 focused on pretesting the preliminary questionnaire in a cross-cultural patient sample (n = 171) using debriefing interviews. Psychometric properties were preliminary determined using a principal component analysis and Cronbach's alpha. We derived 53 relevant SH issues from the literature. Based on HCP and patient interviews, 22 of these 53 issues were selected and operationalized into items. Testing the preliminary 22-item short questionnaire resulted in a change of wording in five items and two communication-related items; no items were removed. Preliminary psychometric analysis revealed a two-factor solution and 11 single items; both scales showed good reliability indicated by a Cronbach's alpha of 0.87 (sexual satisfaction) and 0.82 (sexual pain). Cross-cultural pretesting of the preliminary EORTC SH questionnaire has indicated excellent applicability, patient acceptance, and comprehensiveness as well as good psychometric properties. The final development phase, that is psychometric validation (phase four) including large-scale, cross-cultural field testing of the EORTC SHQ-22, has commenced.
为了评估男性和女性癌症患者和幸存者的性健康的身体、心理和社会方面,开发并预测试了欧洲癌症研究与治疗组织性健康问卷(EORTC SHQ-22)。问卷的构建始于根据全面的文献回顾创建一个相关的性健康问题列表。在深入访谈(第 1 阶段)中,随后由 78 名医疗保健专业人员(HCP)和来自 12 个国家的 107 名患者对这些问题的相关性和优先级进行评估。从提取的问题中进行操作化处理得到项目(第 2 阶段)。第 3 阶段专注于使用汇报访谈对初步问卷进行跨文化患者样本(n=171)的预测试。使用主成分分析和 Cronbach's alpha 初步确定心理测量特性。我们从文献中得出 53 个相关的性健康问题。根据 HCP 和患者访谈,从这 53 个问题中选择了 22 个,并将其操作化为项目。测试初步的 22 项简短问卷导致 5 个项目和 2 个与沟通相关的项目的措辞发生变化;没有删除任何项目。初步心理测量分析显示出双因素解决方案和 11 个单项;两个量表都显示出良好的可靠性,Cronbach's alpha 为 0.87(性满意度)和 0.82(性疼痛)。初步的 EORTC SH 问卷的跨文化预测试表明了极好的适用性、患者接受度和全面性以及良好的心理测量特性。正在进行最终的发展阶段,即心理测量验证(第 4 阶段),包括 EORTC SHQ-22 的大规模、跨文化现场测试。